Calcitonin
"Calcitonin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.
Descriptor ID |
D002116
|
MeSH Number(s) |
D06.472.699.150 D12.644.400.095 D12.644.548.150 D12.776.641.650.095
|
Concept/Terms |
Calcitonin- Calcitonin
- Calcitrin
- Thyrocalcitonin
- Calcitonin(1-32)
|
Below are MeSH descriptors whose meaning is more general than "Calcitonin".
Below are MeSH descriptors whose meaning is more specific than "Calcitonin".
This graph shows the total number of publications written about "Calcitonin" by people in this website by year, and whether "Calcitonin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1982 | 1 | 1 | 2 | 1984 | 1 | 0 | 1 | 1987 | 1 | 0 | 1 | 1989 | 1 | 0 | 1 | 1995 | 1 | 0 | 1 | 2002 | 0 | 1 | 1 | 2003 | 2 | 1 | 3 | 2004 | 0 | 1 | 1 | 2009 | 1 | 1 | 2 | 2010 | 1 | 0 | 1 | 2011 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Calcitonin" by people in Profiles.
-
Schnatz PF, Marakovits KA, Dubois M, O'Sullivan DM. Osteoporosis screening and treatment guidelines: are they being followed? Menopause. 2011 Oct; 18(10):1072-8.
-
Boeck L, Eggimann P, Smyrnios N, Pargger H, Thakkar N, Siegemund M, Marsch S, Rakic J, Tamm M, Stolz D. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP. Eur Respir J. 2011 Mar; 37(3):595-603.
-
Buhaescu I, Yood RA, Izzedine H. Serum procalcitonin in systemic autoimmune diseases--where are we now? Semin Arthritis Rheum. 2010 Oct; 40(2):176-83.
-
Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009 Dec; 34(6):1364-75.
-
Corradi M, Acampa O, Goldoni M, Andreoli R, Milton D, Sama SR, Rosiello R, de Palma G, Apostoli P, Mutti A. Metallic elements in exhaled breath condensate and serum of patients with exacerbation of chronic obstructive pulmonary disease. Metallomics. 2009; 1(4):339-45.
-
Lufkin EG, Sarkar S, Kulkarni PM, Ciaccia AV, Siddhanti S, Stock J, Plouffe L. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial. Curr Med Res Opin. 2004 Mar; 20(3):351-7.
-
Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003 Sep 22; 163(17):2052-7.
-
Yood RA, Emani S, Reed JI, Lewis BE, Charpentier M, Lydick E. Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int. 2003 Dec; 14(12):965-8.
-
Khan A, Tischler AS, Patwardhan NA, DeLellis RA. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study. Endocr Pathol. 2003; 14(3):249-55.
-
Marcus R, Wong M, Heath H, Stock JL. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev. 2002 Feb; 23(1):16-37.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|